These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Nano-enabled strategies to combat methicillin-resistant Staphylococcus aureus. Singh S; Numan A; Somaily HH; Gorain B; Ranjan S; Rilla K; Siddique HR; Kesharwani P Mater Sci Eng C Mater Biol Appl; 2021 Oct; 129():112384. PubMed ID: 34579903 [TBL] [Abstract][Full Text] [Related]
3. [A multicentric study on clinical characteristics and antibiotic sensitivity in children with methicillin-resistant Wu X; Yu H; He LY; Wang CQ; Xu HM; Zhao RQ; Jing CM; Chen YH; Chen J; Deng JK; Shi J; Lin AW; Li L; Deng HL; Cai HJ; Chen YP; Wen ZW; Yang JH; Zhang T; Xiao FF; Cao Q; Huang WC; Hao JH; Zhang CH; Huang YY; Ji XF Zhonghua Er Ke Za Zhi; 2020 Aug; 58(8):628-634. PubMed ID: 32842382 [No Abstract] [Full Text] [Related]
4. Antibiotic delivery from bone-targeted mesoporous silica nanoparticles for the treatment of osteomyelitis caused by methicillin-resistant Staphylococcus aureus. Aguilera-Correa JJ; Gisbert-Garzarán M; Mediero A; Fernández-Aceñero MJ; de-Pablo-Velasco D; Lozano D; Esteban J; Vallet-Regí M Acta Biomater; 2022 Dec; 154():608-625. PubMed ID: 36341887 [TBL] [Abstract][Full Text] [Related]
5. Design, synthesis, and antibacterial evaluation of novel derivatives of NPS-2143 for the treatment of methicillin-resistant S. aureus (MRSA) infection. Chen Y; Ju Y; Li C; Yang T; Deng Y; Luo Y J Antibiot (Tokyo); 2019 Jul; 72(7):545-554. PubMed ID: 30940910 [TBL] [Abstract][Full Text] [Related]
6. Inhibitory effects of aptamer targeted teicoplanin encapsulated PLGA nanoparticles for Staphylococcus aureus strains. Ucak S; Sudagidan M; Borsa BA; Mansuroglu B; Ozalp VC World J Microbiol Biotechnol; 2020 Apr; 36(5):69. PubMed ID: 32333113 [TBL] [Abstract][Full Text] [Related]
7. Australian Group on Antimicrobial Resistance (AGAR) Australian Staphylococcus aureus Surveillance Outcome Program (ASSOP). Coombs GW; Daley DA; Shoby P; Mowlaboccus S Commun Dis Intell (2018); 2022 Dec; 46():. PubMed ID: 36529133 [TBL] [Abstract][Full Text] [Related]
8. Prevalence, antimicrobial susceptibility pattern and multidrug resistance of methicillin-resistant Adhikari P; Basyal D; Rai JR; Bharati L; Budthapa A; Gharti KP; Sah SK BMJ Open; 2023 May; 13(5):e067384. PubMed ID: 37164471 [TBL] [Abstract][Full Text] [Related]
9. Determination of antimicrobial susceptibility patterns in Staphylococcus aureus strains recovered from patients at two main health facilities in Kabul, Afghanistan. Naimi HM; Rasekh H; Noori AZ; Bahaduri MA BMC Infect Dis; 2017 Nov; 17(1):737. PubMed ID: 29187146 [TBL] [Abstract][Full Text] [Related]
10. Rhamnolipid-Coated Iron Oxide Nanoparticles as a Novel Multitarget Candidate against Major Foodborne E. coli Serotypes and Methicillin-Resistant S. aureus. Sharaf M; Sewid AH; Hamouda HI; Elharrif MG; El-Demerdash AS; Alharthi A; Hashim N; Hamad AA; Selim S; Alkhalifah DHM; Hozzein WN; Abdalla M; Saber T Microbiol Spectr; 2022 Aug; 10(4):e0025022. PubMed ID: 35852338 [TBL] [Abstract][Full Text] [Related]
11. Emerging resistance mechanisms for 4 types of common anti-MRSA antibiotics in Staphylococcus aureus: A comprehensive review. Liu WT; Chen EZ; Yang L; Peng C; Wang Q; Xu Z; Chen DQ Microb Pathog; 2021 Jul; 156():104915. PubMed ID: 33930416 [TBL] [Abstract][Full Text] [Related]
12. Antibiotic susceptibility patterns of Kengne M; Fotsing O; Ndomgue T; Nwobegahay JM Pan Afr Med J; 2019; 32():103. PubMed ID: 31223393 [TBL] [Abstract][Full Text] [Related]
13. Synergistic Combinations of FDA-Approved Drugs with Ceftobiprole against Methicillin-Resistant Staphylococcus aureus. Sharma AD; Gutheil WG Microbiol Spectr; 2023 Feb; 11(1):e0372622. PubMed ID: 36519895 [TBL] [Abstract][Full Text] [Related]
14. Antibiotic-loaded nanoparticles for the treatment of intracellular methicillin-resistant Staphylococcus Aureus infections: In vitro and in vivo efficacy of a novel antibiotic. Costabile G; Baldassi D; Müller C; Groß B; Ungaro F; Schubert S; Firestine SM; Merkel OM J Control Release; 2024 Oct; 374():454-465. PubMed ID: 39181163 [TBL] [Abstract][Full Text] [Related]
15. Targeted delivery of rifaximin using P6.2-decorated bifunctional PLGA nanoparticles for combating Staphylococcus aureus infections. Arayici PP; Coksu I; Ozbek T; Acar S Biomater Adv; 2024 Jul; 161():213862. PubMed ID: 38678666 [TBL] [Abstract][Full Text] [Related]
16. Inducible clindamycin and methicillin resistant Staphylococcus aureus in a tertiary care hospital, Kathmandu, Nepal. Adhikari RP; Shrestha S; Barakoti A; Amatya R BMC Infect Dis; 2017 Jul; 17(1):483. PubMed ID: 28693489 [TBL] [Abstract][Full Text] [Related]
17. Platelet membrane-camouflaged silver metal-organic framework drug system against infections caused by methicillin-resistant Staphylococcus aureus. Huang R; Cai GQ; Li J; Li XS; Liu HT; Shang XL; Zhou JD; Nie XM; Gui R J Nanobiotechnology; 2021 Aug; 19(1):229. PubMed ID: 34348721 [TBL] [Abstract][Full Text] [Related]
18. Community-associated, methicillin-susceptible, and methicillin-resistant Staphylococcus aureus bone and joint infections in children: experience from India. Kini AR; Shetty V; Kumar AM; Shetty SM; Shetty A J Pediatr Orthop B; 2013 Mar; 22(2):158-66. PubMed ID: 23249998 [TBL] [Abstract][Full Text] [Related]
19. Prevalence of methicillin-resistant Staphylococcus aureus and pattern of antimicrobial resistance in mastitis milk of cattle in Chitwan, Nepal. Shrestha A; Bhattarai RK; Luitel H; Karki S; Basnet HB BMC Vet Res; 2021 Jul; 17(1):239. PubMed ID: 34233667 [TBL] [Abstract][Full Text] [Related]
20. [Genotyping and drug resistance of methicillin-resistant Staphylococcus aureus]. Yao M; Guan L; Jia W; Wang L; Li G; Wu X; Sun T Zhonghua Shao Shang Za Zhi; 2014 Oct; 30(5):428-32. PubMed ID: 25572893 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]